James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Micron Technology, Inc. (MU), Alcoa Inc (AA) and Gap Inc (GPS) Are 3 of Today’s Worst Stocks

Friday was more than forgettable for Micron Technology (MU), Alcoa (AA) and Gap (GPS). Here's why each used more than their fair share of red ink.

Alcoa Stock – Q3 Earnings Spark Split Concerns

The recent rally from Alcoa stock was upended today when reality set in: The aluminum headwind may not be going away soon enough.

Why Pandora Media Inc (P), eBay Inc (EBAY) and VMware, Inc. (VMW) Are 3 of Today’s Worst Stocks

Pandora Media (P), eBay (EBAY) and VMware (VMW) never even had a prayer of bullishness on Thursday, in light of the news.

Vivus, Inc.: Don’t Overthink This Bullish Move in VVUS

Surprise! Vivus stock has been one of the market's hottest names since September. Maybe we should trust the guy making it happen.

4 Biotech Stocks Now at Bargain Prices

Biotech stocks have been battered of late, but not all these biotechnology names deserved their drubbing. Here are four to pick up while the dust is still settling.